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The antigenicity of synthetic polymers of a-amino acids has been studied in 
various species for different reasons.  The  original impetus  to these  investiga- 
tions  was the search for highly polymerized protein-like  materials  that  could 
possibly be used as plasma volume expanders.  Interest in these materials  has 
increased since their anfigenicity offers a  means  of determining  the minimum 
structural  requirements  for  anfigenicity  in  protein-like  materials.  By  the 
application of quantitative immunochemical studies with small polypeptides it 
may be possible to determine  the size and structure of the antigenic unit and 
the nature of combining sites in the antibody. 
Previous  reports  have  dealt  with  the  antigenicity  in  humans  of  synthetic 
poly-a-glutamic acid  (1)  and random copolymers of glutamic acid and lysine 
(2).  The present  report  will  deal  with  the  study in humans  of additional  co- 
polymers consisting of 3 and 4 amino acids. The anfigenicity of the 4 polymers 
used  in  this  study has  been  established  previously in rabbits  (3)  and  guinea 
pigs (4). 
Materials and Methods 
The copolymers studied for antigenicity in humans are listed in Table I. The methods used 
in preparing the materials and the techniques employed in determining the average molecular 
weights  are presented  in references 5-10.  After  withdrawal  of 50 ml of blood the human 
volunteers were skln-tested  with 0.1 ml of polymer solutions of 10 mg/ml and 1 mg/ml and 
0.1 ml of the 0.15 ~ saline buffer. The individuals then received 5 intramuscular  injections of 
the appropriate  polymer solutions given over a period of 10 days. With antigens GLA5 and 
GLT a total of 125 mg was injected  into 6 and 5 individuals  respectively.  With antigens 
GLA40 and GLAT, 6 individuals in each group received a total of 12.5 mg and other groups 
of 6 received 125 mg. The bleedings and skin testings were repeated about 12 and 21 days after 
the last injection. Because of the responses noted, the bleedings and testings were repeated for 
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several months as indicated in the text. The skin reactions were read after 15 to 20 minutes 
and after 24 and 48 hours. The serum was stored in the cold with 1/10,000 "merthiolate" and 
0.25 per cent phenol as preservatives. The pre- and postimmnnization sera were analyzed for 
antibody by several in vitro and in vivo procedures. 
The microprecipitin technique for analysis of human sera as developed by Heidelberger and 
MacPherson was used (11). Initially, 3.0 ml aliquots of serum (pre- and postimmunization) 
and 0.5 ml of 2 to 3 concentrations of antigen were set up at 0°C and observed for 7 to 10 
days. The tubes were mixed daily. At the end of this period, the washed precipitates were 
analyzed for antibody by the Folin-Ciocalteu reagent. Additional antigen was added to the 
supernatants to insure complete precipitation of the antibody. As the antibody levels in some 
sera were high, only 1 or 2 ml of serum were used for each analysis. 
The indirect or passive hemaggiutination procedure for analysis of antibody as described 
by others was used (12,  13).  Sheep red blood cells preserved in Alsever's solution were used 
within 1 month after collection. The cells were washed three times with 0.15 ~ NaC1 adjusted 
to pH 7.2. They were then adjusted to a 2.5 per cent suspension with buffered saline (pH 7.2 
phosphate-saline).1 Equal volumes of the erythrocyte suspension and freshly prepared 1: 20,000 
tannic acid* were mixed and incubated at 37°C for 15 minutes, centrifuged, and washed once 
TABLE  I 
Copo~m~s  Stu~  ~r Antigenicity in Human  Beings 
Copolymer 
Glu-lys-ala 
Glu-lys-ala 
Glu-lys-tyr 
Glu-lys-ala-tyr 
Ratio of amino acids 
57:38:5 
36:24:40 
58:38:4 
36:24:35:5 
Nomenclatures used 
GLA5 
GLA40 
GLT 
GLAT 
Average molecular 
weight 
50,000 
50,000 
94,000 
35,000 
with buffered saline and then resuspended to the original volume (2.5 per cent). The tanned 
cells were used to absorb the antisera before titration. For preparing the antigen-coated cells, 
the tanned cells were centrifuged and resuspended in 1 ml of buffered saline, pH 6.4. a 
The appropriate antigen was dissolved in adjusted saline (2 mg copolymer per ml tanned 
RBC suspension). 4 mlpH 6.4 buffered saline was then added to the cell suspension and the 
mixture incubated at room temperature for 30 minutes. The suspension was centrifuged and 
the cells washed 3 times with 1 or 2 ml volumes of 1 : 100 normal human serum (previously ab- 
sorbed with tanned cells) and resuspended to the original concentration of 2.5 per cent. The 
normal human serum used above and in the dilutions of sera was first absorbed in a  1:10 
concentration and diluted to 1:100 with buffered saline. 
Antisera dilutions (0.5 ml) were added to 13 X  100 mm tubes. To the serum was added 
0.05 ml antigen-treated tanned cells. The cells were suspended and the tubes allowed to stand 
at room temperature for several hours and then overnight at 5°C. Controls included antigen- 
treated tanned cells mixed with 1:10 and 1:100 dilutions of normal serum and tanned ceils 
mixed with the lowest dilution of antiserum used. Readings were made after 3 hours at room 
1 Prepared by mixing equal amounts of 0.15 ~  NaC1 and a  mixture of 0.15 ~  NasHPO4 
and 0.15 M KH2PO4. 
Prepared in buffered saline from a  stock solution of 1 per cent tannic acid in buffered 
saline. 
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temperature and the following morning after removal of the tubes from the cold room. The 
results were graded according to the procedure used by previous workers. The final hemaggluti- 
nation titers (HA) recorded in the tables are those dilutions of antiserum in which a thin film 
of cells covered the entire bottom of the tube. 
The PCA test in guinea pigs was performed on all sera as described by Ovary (14). 0.1  ml 
of undiluted serum was injected intradermaily into guinea pigs weighing 200 to 250 gm. 3 hours 
later, 1 ml of a solution containing 250 ug of the appropriate copolymer and 0.5 per cent Evans 
blue dye solutions was injected intravenously. The blueing reactions which were present after 
20 minutes at the site of the serum injection were recorded. 
For studies of passive systemic anaphylaxis,  guinea pigs weighing 200 to  250 gm were 
given intraperitoneai injections of sera containing about 40 ~g Ab N  (antibody nitrogen). The 
guinea pigs were injected intravenously 48 hours later with 2 mg of the homologous polymer 
and observed for signs of anaphylaxis. 
Sera from someof thegood reactors were passively transferred to normal volunteers. 0.1 ml 
aliquots of undiluted serum was injected intradermally in the forearm.  24 hours later the 
original sites were injected with the appropriate antigen or 0.15 M NaCI.  Additional virgin 
areas were injected with antigen alone. 
Biopsies of immediate and delayed skin reactions were obtained by sterile surgical pro- 
cedures, fixed in formalin for histological sectioning, and stained with hematoxylin and eosin 
and trichrome. 
Some of the reactors were tested for cross-skin reaction with several of the polymers of 2 
and 3 amino acids which were discussed in previous reports (Table IV). 
RESULTS 
During  the  immunization,  several individuals had  systemic  reactions. 
Volunteer 55(GLA5) 4 had a flare-up  reaction at the original  skin test  site 2 
days after the last  injection. One day after the last injection individual 63 
(GLT) had a flare-up  reaction  at the initial  skin test  site  (Fig.  I). In addition, 
the site  of the last  injection was hard and warm. The individual reported a 
generalized urticarial  reaction with stiffening  of the wrists,  knees, ankles,  and 
elbow joints.  The reaction was relieved after 2 days of treatment with anti- 
histamines. Volunteer 50 (GLA40) reported that the day after  the last  injec- 
tion,  the injection  site  became sore,  tender,  and red.  A reddened area of about 
I0 inches long X  5 inches wide devdoped which persisted  for 2 days and then 
gradually disappeared. Volunteer 52 (GLA40)  noticed that 6 hours after  the 
last  injection,  a red area (100 X  120 ram) developed at the site  of the injection. 
Considerable dii~culty  was experienced in  flexing  the arm. The red area became 
larger  the following  day and then the inflammation gradually disappeared. The 
most severe systemic reactions  were associated  with injections  of GLAT. After 
the 4th injection  individual 41 reported that his arm was red at the injection 
site  (200 X  50 nun) and was slightly  febrile.  Blood was taken and checked for 
possible bacterial contamination.  None was found either in the individual's 
blood or in the antigen being injected. The individual was then skin-tested. 
An immediate erythematous reaction 40 X  40 mm  with a I0 mm  wheal de- 
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veloped. Within 2 hours the skin test area was completely clear. However, in 
5 hours redness began to appear and spread. The test site at 24 hours measured 
140 X  100 mm, at 72 hours 160  X  125 ram, and at 96 hours 180 X  140 mm. 
By 5 to 6 days the inflammation had completely disappeared. Other systemic 
reactions to GLAT were reported by individuals 34 and 38.  Both complained 
of tenderness and inflammation at the injection site the evening of the injection. 
Table II presents the data on the skin reactions observed after immunization. 
Because  of the  extent of  the  reactions,  they are recorded according to  the 
average diameter in millimeters of the erythema, rather than  on a  0  to 4+ 
basis. Whealing reactions are also recorded. There were no positive skin reac- 
tions before immunization. The results are presented only for the  10 mg/ml 
test dose. There were no immediate skin reactions against GLA5. However on 
day 12, there were 3 good and 2 mild delayed reactions. The delayed reactions 
were still present at 72 hours with individuals 55 and 56 (40 and 30 mm reac- 
tions, respectively). On day 21 only no. 55 showed a  delayed reaction. There 
was a greater response against the GLT polymer. Of the 5 volunteers, 2 showed 
good immediate reactions on day 12. These same 2 individuals had good de- 
layed reactions and  another 2  showed fair reactions.  Similar reactions were 
present on day 21.  With the GLA40 polymer on day 12 there were 6 strong 
immediate reactions (Nos. 43, 45, 46, 49, 50, 52) and 5 mild reactions followed 
by 10 strong and 2 weak delayed reactions. Individuals 42, 43, 45, 46, 47, 49, 
and 52 still had good reactions at 72 hours. When tested on day 21 there was 
not  much  change  in  the  number or extent of the  reactions.  There was  no 
significant difference between the two groups receiving the same antigen. The 
GLAT copolymer produced the greatest responses. On day 12, 11/12 individuals 
had good immediate reactions and 12/12 showed good delayed reactions which 
were still present at 72 hours in all individuals except 40. Here, too, on day 21 
there was no major change from the skin reactions noted on day 12. The course 
of the immediate and delayed reactions in all individuals showing both reactions 
was similar; i.e.,  within 1 to 2 hours after skin testing the marked immediate 
reactions were gone and the skin remained clear for several hours. About 6 to 
10 hours later there was a  return of another reaction which was  uniform in 
redness and persisted for at least 72 hours. In repeated testing of the sensitive 
individuals, the same sort of skin reactivity persisted for several months. Figs. 
2 to 4 show representative pictures of the immediate, 3 hour, and 24 hour reac- 
tions. Histological examination of the biopsies of several immediate and delayed 
skin reactions was undertaken. The immediate reactions showed marked edema 
with infiltration of polymorphonuclear cells.  The inflammatory reaction was 
acute in nature and did not damage the vessel walls (Fig. 5). The delayed reac- 
tions showed a heavy perivascular lymphocytic infiltration (Figs. 6, 7). 
The micrograms of antibody N  precipitated by antigen from the 12 and 21 
day  serum  samples  are  presented in  Table II  along  with  hemagglutination P.  H.  MAURER~  B.  Y.  GERULAT~  AND  P.  PINCHUCK  525 
TABLE II 
Response of Human Beings to Injections of Copolymers 
Sub- 
Copoly-  jcct 
~er  used  No. 
Amount 
injected 
Antibody N  PCA 
Cutaneous reactions*  precipitable  reaction~ 
per  ml serum 
Day 12  Day 21 
24  24 
Imm.  hrs.  Imm.  hrs. 
Day 12  Day 21  DI~Y  I)2~Y 
HA titer§ 
Da ¢ 12  Day 21 
mg 
~LA5  54  125  -- 
55  125  -- 
56  125  -- 
57  125  -- 
58  125  -- 
59  125  -- 
~LT  60  125  -- 
61  125  25 
62  125  -- 
63  125  50 
65  125  -- 
;LA40  42  12,5  -- 
43  12.5  20 
44  12.5  15 
45  12,5  35  (10) 
46  12.5  30 
47  12.5  13 
}LA40  48  125  15 
49  125  50 (20) 
50  125  5O (15) 
51  125  12 
52  125  19 
53  125  8 
;LAT  30  12.5  20 
31  12.5  37 
32  12.5  25 
33  12.5  40 
34  12.5  22 
35  12.5  25 
LAT  36  125  50  (15) 
37  123  25 
38  125  27 
39  125  33 
i  40  125 
I  41  125  45  (15) 
#g 
--  0.0 
22  9.5 
--  0.0 
--  9.7 
--  0.0  0,0 
--  :1  0.0  0,0 
10  2.2  4,0 
35  43.6  18.8 
10  1.3  0.0 
60  44.4  26.1 
--  0.0  0.0 
22  11.2  4.4 
22  10.3  7.4 
20  9.9  10.6 
30  16.2  15.9 
15  16.8  14.5 
19  9.8  12.7 
10  0.2  1.0 
50  50.9  53.3 
40  43.6  39.3 
10  0.6  6.0 
28  21.4  18.0 
20  5.9  5.8 
45  19.7  23.9 
30  15.6  13.9 
25  10.5  6.2 
20  8.4  8.0 
35  4.3  17.2 
25  1.6  1.6 
30  20.8  48.8 
45  26.5  27.3 
35  34.2  27.7 
30  6.8  8.7 
--  14.5  7.8 
50  45.2  68.4 
#g 
0.0  0  0 
3.4  0  10 
0.0  0  0 
2,0  0  0 
0  0 
0  0 
0 
14 
0 
20 
0 
5  50 
0  200 
0  2OO 
0  200  (10) 
22  200  (20) 
0  200 
0  <50 
14  500 
17  500 (150) 
0  50 
14  100 
0  50 
20  500 
0  500 
0  500 
0  500 
0  1000 
0  200 
13  2000 
20  1000 
20  1000 
0  1000 
5  5O 
20  5000 
* Values given of diameter of erythema reaction. Values in parentheses refer to size of wheal. 
:~ Average diameter of blueing reaction in guinea pigs. 
§ Reciprocal of serum dilution still giving detectable  hemagglutinatlon.  Values in  parentheses  refer  to HA titent 
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titers. No antibody was precipitated from the preimmunization sera nor were 
significant HA titers obtained on the sera. It will be noted that 2 individuals 
(55, 57) produced significant amounts of antibody by day 12 against GLA5 and 
that the values decreased by day 21. Similar observations were noted with the 
HA results. Only these 2 individuals had weak titers. The response in the GLT 
groups was fair. Individuals 61 and 63 produced very high levels of antibody by 
day 12 (>40 ~g Ab N/ml) and their sera gave HA fiters of 75 and 400, respec- 
tively. The antibody level of the serum of No. 60 was at the limit of detect- 
ability of both methods. By day 21, the antibody level had dropped about 50 
per cent with both individuals. In the GLA40 group good levels of antibody N 
were detected on day 12 in 10 of the 12 volunteers. The levels of antibody on 
day 21 in some cases decreased (Nos. 42, 43) but in most instances remained at 
the same level as the day 12 bleedings. Only No. 51 showed a significant increase 
in antibody from 0.6 ~g N to 6.0/~g N/ml. 
The hemagglutination titers  showed a  fair correlation with  the  antibody 
values. Individuals 49 and 50 had the highest HA titers (500 and 1000), 48 and 
51, low fiters (50 and 100), and the other individuals had intermediate fiters 
(200 to 500). Individual 42 showed a significant decrease in antibody level on 
day 21 as well as a decrease in HA titer. 
In the GLAT group, good levels of antibody were obtained with 11/12 sera 
on day 12. Only No. 35 produced very low levels of precipitating antibody (less 
than 2 #g N/ml). When measured on day 21, it was noted that some individuals 
had a decline in antibody levels (Nos. 32, 38, 40), some had a significant increase 
in the antibody level (Nos. 30, 34, 36, 41),  and with others the level remained 
constant. The HA titers were somewhat parallel to the preclpitin values but 
did reflect the inherent errors of the qualitative HA test. Differences of a tube 
in titration could not be considered significant. 
The data obtained with repeated bleedings from some of the best reactors 
are presented in Table III. In most cases the antibody level decreased with 
time. However, individual 50 exhibited the slowest decline. The last 2 bleedings 
from this  individual taken 6  weeks apart  showed the same  antibody level. 
Moderate Ab N levels were present in individuals 41, 49, 61 and 63 on March 
19,  1962, but most of the other volunteers showed no levels of precipitating 
antibody and negligible HA titers. 
Some of the supernatants from the precipitin analysis were also tested with 
tanned cells. There were definite reductions in the HA titers in cell-absorbed 
sera. 
The results of testing the sera by PCA are presented in Table II. None of the 
sera from the GLA5 group gave positive reactions. In the GLT group the serum 
from individual 61 gave a positive PCA reaction on day 12 and individual 63 
was positive on days 12 and 21. In the GLA40 group on day 12 sera from 46, 
49, 50, and 52 and on day 21 sera from 46, 50, and 52 gave good PCA reactions. P. H. MA.URER,  B. F. GERULAT,  AND  P. PINCHUCK  527 
Why serum 40 with 53.5 #g Ab N/ml did not give a reaction is not known at 
present, but will be discussed later.  Subsequent bleedings were also tested and 
only Nos. 46 and 50 with 26.0 and 22.6 #g Ab N  per ml of serum gave positive 
TABLE III 
Antibody Levels in ttuman Volunteers at Varying  Times after Injection 
i 
Antibody  N 
Copolymer  Subject  Date of bleeding  precipitable per ml  HA titer* 
serum 
GLT 
GLA~ 
61 
63 
49 
50 
36 
37 
41 
GLAT 
Jan. 29, 1962 
Feb. 19, 1962~; 
Mar.  19, 1962 
Jan. 29, 1962 
Feb. 19, 1962:1: 
Apr. 6, 1962 
Dec. 4, 1961 
Feb. 1, 1962~: 
Mar. 19, 1962 
Dec. 4, 1961 
Feb. 1, 1962~: 
Mar. 19, 1962 
Dec. 11, 1961:~ 
Jan. 18, 1962~ 
Mar. 19, 1962 
Dec. 11, 1961 
Jan. 18, 1962 
Mar. 19, 1962 
Dec. 11, 1961~ 
Jan. 18, 1962~ 
Mar. 19, 1962 
t*g 
43.6 
21.7 
9.8 
44.4 
31.8 
10.6 
50.9 
19.5 
6.4 
43.6 
22.6 
25.8 
27.3 
14.0 
3.6 
27.7 
21.1 
2.1 
83.6 
32.3 
18.0 
75  (so) 
100 
4oo  (100) 
20o  (20) 
20  (o) 
200 
500 
100 
(35) 
100o (5o) 
1500 
500  (50) 
25o  (so) 
500  (35)  . 
200  (35) 
75 
5ooo (15o) 
100o (15o) 
* Values in parentheses refer to HA titers obtained after absorption of serum with antigen. 
:~ Sera used for passive anaphylaxis studies in guinea pigs. 
reactions, whereas sera 45, 49, and 52 with 21.8, 19.5 and 11.6 #g Ab N  per ml, 
respectively did not give positive PCA reactions with undiluted serum. 
In the GLAT group positive PCA reactions with the day 12 bleedings were 
given by Nos. 30, 37, 38, and 41. Positive reactions were also obtained with the 
day 21 bleedings from the individuals,  with the exception of No. 36 who had 
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later were  tested  only No.  41  gave  a  positive PCA reaction although  there 
were  10 to 20 #g Ab N/ml serum in some of the sera that did not give PCA 
reactions. 
None of the guinea pigs injected with 40 #g antibody N  from the sensitized 
individuals showed any signs of systemic anaphylaxis when challenged with the 
antigen. The sera used are indicated in Table III. 
TABLE IV 
Additional Copolymers Used in Testing Cross-Skin Reactions 
Copolymer  Ratio of amino acids  Nomenclature used  Average molecular weight 
Glu-ala  60:40  GA  33,000 
Glu-lys  60: 40  GL  64,000 
Glu  100  G  80,000 
TABLE V 
Cross-Skin Reactions of Human Beings to Testing with Various Polymers* 
Subject 
Group  No. 
GLAT  30 
31 
34 
36 
41 
GLA40  44 
49 
50 
51 
52 
53 
GLAT 
30 
30 
30 
50 
50 
25 
35 
15 
35 
GLA40 
as l2o 
0  15 
38]  30 
30  I  o 
25'30 
33  40 
12  30 
45  45 
35  35 
25  35 
28140 
GA  GLA5 
0  0 
30  0 
20  0 
28  0 
40  0 
0  0 
0  0 
25  0 
10  25 
25  0 
0  0 
GLT 
0  0 
30  0 
20  0 
0  0 
25  8 
0  0 
0  0 
8  0 
0  0 
0  0 
0  0 
GL  G 
0  0  0,  0 
0  0  0  0 
0  0  0  0 
35  0  0  0 
15  0  30  0 
0  0  0  0 
0  0  0  0 
25  0  15  0 
13  0  20  30 
20  0  0  0 
0  0  0  0 
* Homologous reactions obtained with solution 1 mg/ml, heterologous polymers l0 mg/ml. 
Observations made at 20 minutes (immediate reactions) and 24 hours (delayed reaction). 
The sera that were used to determine whether the P-K type of antibody was 
present were those from individuals 31, 35, 38, 40 and 41 for the GLAT group 
and from individuals 42, 45, 49,  50 and 53 in the  GLA40 group.  Each normal 
recipient received several  intradermal injections of  serum from 2  recipients. 
Pre- and postimmunization, antigen-absorbed, and heated sera were injected. 
In no case  was  a  positive P-K reaction noted upon injection of antigen 24 
hours later into the test sites. 
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individuals in the GLA40 and GLAT groups were skin tested, with several of 
the polymers listed in Table IV. Representative results obtained are shown in 
Table V. 
It will be seen that in the GLA40 group in general, good cross-reactions, both 
immediate and delayed were shown by GLAT and GA. Three individuals (50, 
51,  52)  showed reactions against GLA5 and GL. Two of these (50, 51)  also 
showed reactions with G. No reactions were obtained with GLT in this group. 
In the GLAT group,  good cross-skin reactions  were shown with GLA40 and 
GA. Four individuals showed immediate reactions against GLA5, three against 
GLT and two against GL. Only one individual (No. 41), who was the best reac- 
tor in the group,  showed a good skin reaction with poly G. In no case were 
reactions noted in either group with the control diluent (0.15 ~t NaC1). 
DISCUSSION 
The data indicate that polymers GLAT, GLA40, GLT, and GLA5 are anti- 
genic for man in the order listed. Earlier studies have established the antigenic- 
ity of these polymers for rabbits (3) and guinea pigs (4). As shown in a previous 
publication the glu-lys polymers were not antigenic in humans under the same 
conditions  of immunization and  testing  (2). This  would  indicate  that  the 
introduction of a small amount of a third amino acid (5 tool per cent) into the 
glu-lys copolymers caused sufficient changes in the molecule to make it anti- 
genic. From the limited number of individuals injected with GLA5 and GLT 
it appears that GLT was a better antigen and that tyrosine may be a good 
enhancer of antigenicity. However, the data we have presented in rabbits with 
these polymers and glu-ala  (3)  as well as the good response  in the humans 
against GLA40 would indicate that tyrosine per se was not enhancing anti- 
genicity. Other factors such as the formation of "foreign"  polypeptide sequences 
and the possible stabilization of structures by alanine may play important roles 
in the nature of the immune response produced.  In the development of the 
immune response as measured  by skin reactivity in the humans, there appear 
to be two distinct reactions:  an immediate type of reaction which is inflamma- 
tory in nature, and transient, and a delayed cellular reaction which may persist 
for several  days. The latter reaction (cellular sensitivity) develops first; i.e., 
individuals who have little or no detectable antibody and no immediate reac- 
tion show good delayed reactions  (individuals 56, 58, 59). There were however, 
several  instances  of good levels of precipitating antibody in the absence  of 
immediate reactions  (individuals 55, 57, 42, and 40) and also examples of good 
immediate skin reactions  with very low levels of precipitating antibody (Nos. 
51, 53, 35). In general, however, there was a fair correlation between the imme- 
diate type of skin reactivity and the antibody level. The studies of passive 
transfer of the serum into normal recipients did not indicate the presence of the 
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and 53, who had good skin reactivity and low levels of precipitating antibody, 
and did not give a positive P-K reaction. None of the other sera used gave a 
positive transfer reaction. There was not too good a  correlation between the 
levels of precipitating antibody and the HA titers. Even within responses to a 
given antigen, the antibody levels as measured by precipitin analysis varied 
sixfold with only twofold differences in HA titers of tanned red blood cells. 
There were also instances of low levels of antibody and high HA titers (Nos. 
45, 46). It should be borne in mind that the HA fiters are only qualitative and 
that the titers depend not only on how much antibody is in the serum being 
analyzed, but also on how much antigen gets on the red cells, a variable which 
cannot be effectively controlled. It is hoped to couple the antigens to the red 
cells by covalent bonds (bis-diazotized benzidine or toluidine 2,4-diisocynate) to 
standardize the amount of each antigen on the cell. It is not known at present 
whether the  same antibody responsible for precipitating activity is  also re- 
sponsible for the HA activity of the sera. The specificity of the HA reaction 
was shown by the negative titers with the preimmunization sera. 
From  the limited data  presented on serially  absorbed antisera it appears 
that it is possible some HA activity was still present in the supernatants. This 
problem is being studied further at present. It may be related to the reports of 
others that in the antigen-antibody systems with synthetic polymers not all of 
the antigen is precipitated at equivalence and that the supernatants still have 
soluble antigen-antibody  complexes (15-17). The results with the PCA reactions 
were also not clear cut. In contrast to the studies with rabbit antisera against 
the same copolymers, the sensitivity here with human sera is not very great. 
Most of the sera with less than 15/zg antibody N per ml did not give positive 
PCA reactions. One serum (No. 36) with 48.8 #g Ab N per ml also did not give 
a  PCA reaction. This is in agreement with previous observations indicating 
that the method is less sensitive for detecting human antibody. Ovary has 
mentioned that with human sera if the concentration is 50 ug Ab N per ml then 
it is possible to detect antibody easily when the serum is diluted to about 12 ~g 
Ab N per ml (18). In general, the PCA test for human antibody is 100 times less 
sensitive than for rabbit antibody and may be related to its inability to fix to 
sites in guinea pig skin (19).  Human gamma globulin also does not compete 
well with rabbit gamma globulin for fixation to guinea pig skin (20).  Another 
factor of importance which may explain the  absence  of PCA in the  serum 
having 48 #g Ab N per ml is the inablity of antibody of 19S size to give a PCA 
reaction (21).  19S antibody when present can inhibit the ability of 7S antibody 
to give a good PCA reaction. If the sera have mixtures of 7S and 19S antibody, 
reduced PCA titers can result. Studies are under way to fractionate the sera 
chromatographically and  learn  if  antibody activity is  associated  with  19S 
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the human sera is based on the increased time needed for positive reactions  to 
be obtained in agar diffusion compared  with the time needed for the rabbit 
sera containing equivalent amounts of antibody. 
The absence of systemic anaphylaxis in the guinea pigs given 40/~g antibody 
N  would also be in agreement with the observations  reported above  on the 
PCA reactions. 
The immune response against the copolymers resembled antiprotein reactions 
in the sense that the antibody levels did decrease rather than remain constant 
for a long period  of time as has been found with antipolysaccharide levels in 
humans (22-24). The half-life of the antibody level in the various individuals 
varied considerably from 2 to 6 weeks (25). However, it should be realized that 
the individuals were skin-tested at each bleeding with 100 #g of material and 
this injection may have promoted a booster  response. With many of the sera 
not listed in Table II the antibody levels at the last testing (April, 1962) were 
not detectable by the precipitin reaction but these individuals still had definite 
immediate reactions and very good delayed reactions. The extent of the delayed 
skin reactions did not decrease much during the 5 month study but the immedi- 
ate reactivity did decline as did the antibody level. 
The data on the specificity of the individual responses against the copolymers 
as measured by skin reactions presented in Table V, indicate that there are 
several patterns to the response. This will be demonstrated further in subse- 
quent publications  dealing with the immunochemical studies of cross-reactions 
of various copolymers  with these  antisera. With the anti-GLA40  sera there 
were good cross-skin reactions with GLAT and GA showing that these 3 poly- 
mers have determinant groups in common. The fact that some of the individuals 
reacted to GLA5, GL, and also poly G indicates  a non-uniformlty in response 
against the mixed copolymer. This has been shown to be true of these types of 
copolymers in rabbits and guinea pigs (3, 4). Not all individuals exposed to an 
antigen will necessarily  react against the same determinant groupings.  Some 
individuals have reacted against GA groupings,  other against GL, and still 
others against poly G.  The same sort of situation obtains with the anti-GLAT 
sera. More will be learned about the nature of the specific antigenic  groupings 
from inhibition studies  with di-, tri-,  tetra-, etc.  peptides  of  different amino 
acids. 
As for the practical application of the findings in this report, it appears  that 
the introduction of 5 tool per cent a third amino acid (alanine or tyrosine into 
the  glu-lys  polymer)  removes  the polymer from consideration  as  a  plasma 
expander.  Whether the introduction of other neutral or polar amino acids will 
enhance  the antigenicity of the glu-lys copolymer is contemplated for study 
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SUMMARY 
It has been shown that the polymers GLA5, GLT, GLA40, and GLAT are 
antigenic in human beings. Both immediate skin reactions and delayed (cellu- 
lar) reactions were observed. 
The antibody produced reacted well in the precipitin reaction, agglutinated 
antigen coated tanned sheep cells, was less effective in inducing PCA reactions, 
and failed to sensitize guinea pigs for passive systemic anaphylaxis. 
The immediate skin reactivity appeared not to be related to the P-K anti- 
body. The  delayed reaction  was  histologically distinct from the  immediate 
reaction and consisted of perivascular lymphocytic  infiltration in contrast to the 
predominantly polymorphonuclear cells  in the latter reaction. The antigenic 
response against the polymers resembled that observed with proteins.  From 
cross-reactions it appears that the response is heterogeneous in the sense that 
not all individuals react against the same groupings in the complex polymers. 
The authors wish to acknowledge  the technical assistance of Mrs. M. Lowy  and Mrs. J. 
Flaherty. The cooperation  and assistance of Dr. K. Judy in performing  the surgical biopsies 
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EXPLANATION OF PLATES 
Plate 70 
Fxo. 1.  Flare-up reaction at initial skin test site observed in volunteer 63 8 days 
after skin testing. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 116  PLATE  70 
(Maurer  el  al.: Antigenicity of polypeptides in humans) P]ate 71 
FIG. 2.  Immediate skin reactions observed 20 minutes after testing vo]unteer 50 
12  days after last injection (GLA40). Results of tests with  10 mg/ml and  1 mg/ml 
are indicated. 
FIo. 3.  Appearance of same skin test sites 3 hours later. 
FIG. 4.  Appearance of typical delayed reactions (24 hours) after injection of 2 con- 
centrations of antigen. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 116  PLATE  71 
(Maurer  et  al.: Antigenicity of polypeptides in humans) Plate 72 
Fic.  5.  Histological  section  (trichrome)  of biopsy of immediate skin reaction  of 
sensitized individual (No. 30). Note predominant polymorphonuclear cell infiltration. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 116  PLATE  72 
(Maurer  el  al.:  Antigenicity of polypeptides in  humans) Plate 73 
FIGS. 6 and 7.  Histological sections (trichrome) of biopsies of 24 hour skin reactions 
of 2 sensitized individuals (Nos. 33 and 52). Note almost pure lymphocytic response. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  116  PLATE  73 
(Maurer  eta/.: Antigenicity of polypeptides in humans) 